AVTX — Recent News Coverage
All news mentioning AVTX in ESEN's AI-graded feed
News stories with AVTX as an affected ticker. Each article is graded by ESEN AI for impact level and direction (up/down/flat) on AVTX. See /coverage/AVTX for the 30-day aggregate.
SEEKINGALPHA.COM
·
2026-10-25
NEUTRAL
BULLISH
CORR0.32
Avalo Therapeutics: Contrarian 'Buy' Ahead Of Abdakibart's Phase 3 (NASDAQ:AVTX)
$AVTX
◈ ESEN AI
AVTX has generated positive momentum following preliminary LOTUS trial results that validate progression toward a Phase 3 pivotal study in hidradenitis suppurativa (HS). The data package appears sufficiently robust to m…
MANILATIMES.NET
·
2026-06-26
NEUTRAL
BULLISH
CORR0.42
Avalo Therapeutics to Join the Russell 2000® and Russell 3000® Indexes
$AVTX
◈ ESEN AI
Avalo Therapeutics (AVTX) has been selected for inclusion in the Russell 2000 and Russell 3000 indexes, effective June 26, 2026. This represents a passive index reconstitution event rather than a fundamental business de…
FINANCE.YAHOO.COM
·
2026-06-23
NEUTRAL
BULLISH
CORR0.42
Why Avalo Therapeutics, Inc. (AVTX) Is Among the Best Low Priced Stocks to Get Rich in 2026
$AVTX
◈ ESEN AI
AVTX received institutional initiation coverage from Bank of America on June 12, with a Buy rating and $35 price target, positioning the company as a simplified immunology play following positive Phase 2 clinical data. …
MANILATIMES.NET
·
2026-06-23
LOW
NEUTRAL
CORR0.15
Avalo Therapeutics Appoints Ron Philip to Board of Directors
$AVTX
◈ ESEN AI
Avalo Therapeutics (AVTX) announced a board appointment that signals incremental governance reinforcement rather than operational or clinical advancement. Ron Philip's 30-year biopharmaceutical pedigree—including produc…
EXPLORE OTHER FILTERS